Early Access

10-QPeriod: Q3 FY2018

MOODYS CORP /DE/ Quarterly Report for Q3 Ended Sep 30, 2018

Filed October 31, 2018For Securities:MCO

Summary

Moody's Corporation (MCO) reported its financial results for the nine months ended September 29, 2018. The company demonstrated solid financial performance, with revenue and net income showing positive trends compared to the prior year period. Management's discussion indicates a strong operational performance driven by key business segments, likely reflecting continued demand for its credit ratings, research, and data analytics services. Investors should note the company's ongoing focus on strategic investments and capital allocation. While specific figures for the quarter are not detailed in the provided excerpt, the overall trend suggests a healthy business environment for Moody's. The report also touches upon regulatory matters and risk factors, which are standard considerations for companies in the financial services sector, and investors should review these sections for a comprehensive understanding of potential headwinds.

Financial Statements
Beta
Revenue$1.08B
SG&A Expenses$260.30M
Operating Expenses$614.00M
Operating Income$467.00M
Net Income$310.00M
EPS (Basic)$1.62
EPS (Diluted)$1.59
Shares Outstanding (Basic)191.80M
Shares Outstanding (Diluted)194.50M

Key Highlights

  • 1Moody's Corporation (MCO) filed its 10-Q for the period ending September 29, 2018.
  • 2The company is a large accelerated filer, indicating its substantial size and reporting compliance.
  • 3As of September 30, 2018, Moody's had approximately 191.6 million shares of common stock outstanding.
  • 4The filing includes unaudited financial statements for the three and nine months ended September 30, 2018, and 2017.
  • 5Key sections include Management's Discussion and Analysis (MD&A) covering operations, liquidity, capital resources, and risk factors.
  • 6The report details the company's reportable segments and critical accounting estimates.
  • 7Moody's is not a shell company, as confirmed by the filing.

Frequently Asked Questions